12th week of 2011 patent applcation highlights part 38 |
Patent application number | Title | Published |
20110071268 | SILICONE POLYOXAMIDE AND SILICONE POLYOXAMIDE-HYDRAZIDE COPOLYMERS - A copolymer comprises at least two repeating units of formula I | 2011-03-24 |
20110071269 | PROCESS FOR PRODUCTION OF POLYSILANE COMPOUND - A method for easily producing high-purity polydimethylsilane or polydiphenylsilane, where by-products such as alkali metal salt and alkaline earth metal salt can be efficiently removed, is provided. Dimethyldichlorosilane or diphenyldichlorosilane is reacted with an alkali metal such as metal sodium and metal magnesium and/or an alkaline earth metal in an organic solvent such as toluene to obtain crude polydimethylsilane or crude polydiphenylsilane, methanol having dissolved therein an ether ester-type nonionic surfactant or a surfactant such as alkylbenzenesulfonate is added to the crude polydimethylsilane or the crude polydiphenylsilane to deactivate the remaining alkali metal and alkaline earth metal, and the crude polydimethylsilane or the crude polydiphenylsilane is washed with water in the presence of a surfactant to efficiently remove an alkali metal salt, an alkaline earth metal salt and the like, whereby high-purity polydimethylsilane or polydiphenylsilane is obtained. | 2011-03-24 |
20110071270 | SILICONE POLYOXAMIDE AND SILICONE POLYOXAMIDE-HYDRAZIDE COPOLYMERS - Silicone polyoxamide and silicone polyoxamide-hydrazide copolymers comprise at least two repeating units of formula I | 2011-03-24 |
20110071271 | SMART DEVICES BASED ON A DYNAMIC SHAPE MEMORY EFFECT FOR POLYMERS - Certain polymer materials, including perfluorosulfonic acid ionomers, have been found to be capable of being deformed from an initial permanent shape into three or more temporary shapes. An article thus formed from such a polymer material may be used initially in a final temporary shape. As the article is progressively heated, the polymer composition reverts successively from its final temporary shape through its intermediate temporary shapes. If a suitable temperature is reached, the original permanent shape is recovered. The article may be devised to serve successive functions in each of its several shapes. | 2011-03-24 |
20110071272 | FLUOROSULFONYL GROUP-CONTAINING MONOMER AND ITS POLYMER, AND SULFONIC ACID GROUP-CONTAINING POLYMER - A fluorosulfonyl group-containing monomer having a high polymerization reactivity and plural fluorosulfonyl groups, a fluorosulfonyl group-containing polymer and a sulfonic acid group-containing polymer, obtained by using the monomer. | 2011-03-24 |
20110071273 | CHIMERIC ANTIGEN-SPECIFIC T CELL-ACTIVATING POLYPEPTIDES - The invention provides an immunogenic or antigenic polypeptide containing a translocation domain, a peptide epitope, at least one biologically active agent, and cleavage sites. These polypeptides are useful for activating T cell responses. | 2011-03-24 |
20110071274 | IMMOBILISATION OF CHELATING GROUPS FOR IMMOBILISED METAL ION CHROMATOGRAPHY (IMAC) - The present invention refers to a method for binding a polycarboxylic acid to a solid phase. Further, the invention refers to a solid phase having a polycarboxylic acid immobilized thereto and methods of using the solid phase, e.g. for purifying His-tagged recombinant polypeptides. | 2011-03-24 |
20110071275 | Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine - The present invention describes novel neuroprotective and multifunctional intra- and inter-molecular redox coupled polynitroxylated pegylated carboxy hemoglobins as high therapeutic index agents for un-met medical needs or diseases, which require acute or chronic alleviation of oxidative stress and correction of inadequate blood flow resulting from physical injury, ischemia, reperfusion injury, and inflammation injury in either or both pre-hospital and in-hospital transfusion and critical care medicine. These hemoglobins are triple-modified with a focus on therapeutic activities rather than oxygen carrying ability. | 2011-03-24 |
20110071276 | Method of modifying a monoclonal antibody - Methods, compositions, and kits relating to selecting a prophylactic or therapeutic antibody less likely to induce or aggravate an anti-antibody response in a subject administered the antibody. An antibody for administration to a subject may be selected to match, or at least more closely resemble, the allotypic phenotype of the subject's endogenous antibodies. | 2011-03-24 |
20110071277 | RESISTIN ANTAGONISTS AND THEIR USE - Resistin antagonists, including antibodies reactive with defined epitopes, are disclosed. Antigens useful for raising antibodies against human resistin are also disclosed. Methods of utilizing resistin antagonists to treat or alleviate the symptoms of the diseases with aberrant fibroblast activity including interstitial lung diseases, hypertrophic scarring, keloid scarring and scleroderma are also disclosed. Methods of utilizing resistin as a biomarker to diagnose the risk and/or progression of osteoarthritis are also disclosed. Further disclosed are methods of utilizing the antagonists to treat or alleviate the symptoms of osteoarthritis. | 2011-03-24 |
20110071278 | ANTIBODIES THAT RECOGNIZE CUTTING EDGE WITHIN THE TGF- BETA ACTIVATION CONTROLLING REGION - It is an object of the present invention to provide antibodies capable of detecting an active TGF-β generation reaction that is specific to pathogenesis, tissues, or isoforms. The present invention provides antibodies against an LAP fragment (or latent TGF-β) generated as a result of generation of active form of human TGF-β1, human TGF-β2 and human TGF-β3. The antibodies are able to specifically recognize respective cutting edges within protease cleavage sites existing in the region from the amino acid residue glycine at position 51 to the amino acid residue arginine at position 110 of human TGF-β1, and corresponding regions of human TGF-β2 and human TGF-β3. | 2011-03-24 |
20110071279 | MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION - An immunogenic composition having 13 distinct polysaccharide-protein conjugates and optionally, an aluminum-based adjuvant, is described. Each conjugate contains a capsular polysaccharide prepared from a different serotype of | 2011-03-24 |
20110071280 | Methods and Compositions for Concentrating Secreted Recombinant Proteins - Methods and compositions are described that relate to obtaining concentrated preparations of secreted recombinant proteins. These proteins are expressed in the form of fusion proteins with a chitin-binding domain (CBD). The fusion proteins are capable of being concentrated in the presence of chitin. Also described is: a shuttle vector that includes a modified LAC4 promoter; a chitinase-negative host cell; a CBD capable of eluting from chitin under non-denaturing conditions; and sterilized chitin, which can be optionally magnetized for facilitating recovery of recombinant protein. | 2011-03-24 |
20110071281 | Electrolysis for protein modification - The present invention relates to a method of protein electrolysis, comprising: (a) providing a protein sample, which contains a salt selected from alkali metal salts or alkaline earth metal salts having a concentration of 20 mM or above; (b) electrolytically reducing said protein sample; (c) obtaining an electroreduced protein sample. The present invention also relates to a protein obtained by the above-mentioned protein electrolysis method, and a use of said method for protein modification. | 2011-03-24 |
20110071282 | PROCESS FOR THE PREPARATION OF NAPHTHALEN-2-YL-PYRAZOL-3-ONE INTERMEDIATES USEFUL IN THE SYNTHESIS OF SIGMA RECEPTOR INHIBITORS - The invention relates to a process for preparing naphthalen-2-yl-pyrazol-3-one intermediates, tautomers, and salts thereof, to novel intermediates, and to the use of the intermediates in the preparation of sigma receptor inhibitors. | 2011-03-24 |
20110071283 | HAEMOCOAGULASE - The present invention provides a venene haemocoagulase gene and its expression for the functional protein. The haemocoagulase gene of the present invention has a nucleotide sequence shown by the sequence list SEQ ID NO: 1 or the mutated nucleotide sequence formed by replacement, depletion, or addition of one or more nucleotide based on the said nucleotide sequence with an equivalent function. The said haemocoagulase has amino acid sequence shown by SEQ ID NO: 2. Haemocoagulase of the present invention has an obvious hemostatic effect, a broad effective dose range, safe and reliable application, which creates good conditions for the development of genetic engineering products of recombinant haemocoagulase in the future. | 2011-03-24 |
20110071284 | NOVEL B-TYPE GENE FROM OIL PALM - The present invention relates generally to genetic sequences and their complementary forms capable of facilitating the modification of a phenotype of a plant. More particularly, the present invention relates to polynucleotide sequences defining B-type genes, to the proteins encoded thereby, to methods for isolating such polynucleotides and to nucleic acid constructs for the expression thereof. The present invention further provides cells, particularly transformed bacterial or plant cells and to differentiated tissue including whole plants and their progeny comprising cells which contain these nucleic acid constructs or parts of the constructs. Plants and parts of plants, such as flowering and reproductive parts including seeds, also form part of the present invention. The genetic sequences of the present invention may be used inter alia for the production of plants and, in particular, oil palm plants, which have modified phenotypes and/or which exhibits more highly desired characteristics such as, for example, male sterility or plants in which the sex ratio may be manipulated, and for the diagnosis and, preferably, elimination of the mantled phenotype. | 2011-03-24 |
20110071285 | LOW-MOLECULAR SERINE PROTEASES INHIBITORS COMPRISING POLYHYDROXY-ALKYL AND POLYHYDROXY-CYCLOALKYL RADICALS - The invention relates to novel amidines and quanidines, the production and use thereof and the use thereof as trypsine-type serine protease competitive inhibitors, especially thrombine and compliment proteases CIs and C1r. The invention also relates to pharmaceutical compositions which contain said compounds as active ingredients, in addition to the use of the compounds as thrombine inhibitors, anticoagulants, compliment inhibitors and anti-inflammatory agents. The novel compositions are characterised by the linkage of a serine protease inhibitor having amidine or guanidine functions with an alkyl radical having two or more hydroxyl functions, whereby said alkyl radical is derived from sugar derivates. Several sugar structural components or components derived from sugar can therefore be linked to each other. Said principle of linking sugar derivates enables oral active compounds to be obtained. | 2011-03-24 |
20110071286 | NOVEL PREPARATION PROCESS - A process for preparing compounds of the formula (I) | 2011-03-24 |
20110071287 | PROCESS FOR THE PREPARATION OF EFAVIRENZ - The present invention relates to a process for the preparation of Efavirenz (Formula I), wherein triphosgene is used as a cyclizing agent. | 2011-03-24 |
20110071288 | INTERMEDIATE USEFUL IN PREPARING CERTAIN PYRROLOTRIAZINE COMPOUNDS AND A PROCESS FOR MAKING THE INTERMEDIATE - The invention relates to 2,4-dibromoropyrrolo[1,2-f][1,2,4]triazine, which is an intermediate useful in preparing 2,4-disubstituted pyrrolotriazine compounds, and a process for preparing the intermediate. | 2011-03-24 |
20110071289 | AMINOPYRAZOLE AMIDE DERIVATIVE - Disclosed is a compound represented by the formula (1) below or a pharmaceutically acceptable salt thereof, which is useful as an agent for prevention and/or treatment of diabetes and the like. | 2011-03-24 |
20110071290 | Process And Catalyst - Aromatic or heteroaromatic nitro compounds are catalytically hydrogenated to the corresponding amines in the presence of a platinum catalyst comprising elemental platinum on a support; the platinum catalyst is modified with a molybdenum compound and a phosphorus compound wherein the phosphorus has an oxidation state of less than +5, e.g. hypophosphorous acid; the catalyst is particularly useful in the hydrogenation of nitro compounds with halogen and/or sulfur-containing substituents. | 2011-03-24 |
20110071291 | HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME - A hydrazide compound represented by the formula (1): | 2011-03-24 |
20110071292 | LIGHT-EMITTING MATERIAL COMPRISING ORTHOMETALATED IRIDIUM COMPLEX, LIGHT-EMITTING DEVICE, HIGH EFFICIENCY RED LIGHT-EMITTING DEVICE, AND NOVEL IRIDIUM COMPLEX - A synthesis method of a compound represented by following formula (24), the method comprising reacting at least one of a ligand and a dissociation product thereof with an iridium compound at a room temperature or at an elevated temperatures in the presence or absence of a solvent or in the presence or absence of a base: | 2011-03-24 |
20110071293 | LIGHT-EMITTING MATERIAL COMPRISING ORTHOMETALATED IRIDIUM COMPLEX, LIGHT-EMITTING DEVICE, HIGH EFFICIENCY RED LIGHT-EMITTING DEVICE, AND NOVEL IRIDIUM COMPLEX - A synthesis method of a compound represented by formula (23), the method comprising reacting at least one of a ligand and a dissociation product thereof with an iridium compound at a room temperature or at an elevated temperatures in the presence or absence of a solvent or in the presence or absence of a base: | 2011-03-24 |
20110071294 | Homogeneous Dimerization Catalysts Based on Vanadium - A series of new bis(imino)pyridine vanadium(III) complexes was synthesized according to formula: | 2011-03-24 |
20110071295 | PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES - Processes are disclosed for preparing piperidine derivative compounds of the formulae I, II or III: | 2011-03-24 |
20110071296 | Preparation of 10-Keto Morphinans by Benzylic Oxidation - The present invention provides processes for the preparation of 10-keto and/or 10-hydroxy morphinans. In particular, the invention provides to processes for preparing a 10-keto morphinan by chromium-catalyzed benzylic oxidation of a morphinan with a periodic acid. | 2011-03-24 |
20110071297 | Methods for Producing Hydrocodone, Hydromorphone or a Derivative Thereof - The present disclosure generally relates to methods for producing opioid derivatives. More particularly, the present disclosure relates to the preparation of hydromorphone, hydrocodone, or a derivative thereof, by means of a non-catalytic hydrogenation reaction of thebaine, oripavine or a derivative thereof, respectively, using a hydrazide reagent, followed by hydrolysis of the hydrogenated intermediate at a low temperature and for a short period of time. Additionally, the present disclosure relates to a composition comprising the desired hydromorphone, hydrocodone, or a derivative thereof, in combination with a 6-beta compound that is structurally related thereto. | 2011-03-24 |
20110071298 | Processes and Intermediates - The invention relates to processes and compounds useful for producing modified aspartic acid derivatives, such as aspartic acid aldehyde moieties. Aspartic acid derivatives are useful for preparing caspase inhibitors and/or prodrugs thereof. | 2011-03-24 |
20110071299 | One-Pot Preparation of Hexahydroisoquinolines from Amides - The present invention provides an efficient process for the preparation of hexahydroisoquinolines from amides. In particular, the invention provides a good yielding, one-pot process for the synthesis of hexahydroisoquinolines. | 2011-03-24 |
20110071300 | One-Pot Preparation of Hexahydroisoquinolines from Dihydroisoquinolines - The present invention provides an efficient process for the preparation of hexahydroisoquinolines from dihydroisoquinolines. In particular, the invention provides a good yielding, one-pot process for the synthesis of hexahydroisoquinolines. | 2011-03-24 |
20110071301 | ABETA-BINDING SMALL MOLECULES - In one aspect, the present invention provides for compounds and labeled compounds of Formula I, and pharmaceutical compositions thereof. In another aspect, the present invention provides for methods of using compounds or labeled compounds of Formula I for various therapeutic and imaging purposes, including, but not limited to, treating Alzheimer's disease in patient and imaging Aβ peptide aggregates in a patient. | 2011-03-24 |
20110071302 | PROCESS FOR PREPARING INTERMEDIATE COMPOUND FOR SYNTHESIZING AN ANTIULCERANT - The present invention relates a novel method of preparing an intermediate which is useful for synthesizing an antiulcerant. The present invention provides a method of preparing an intermediate of an antiulcerant which can obtain a high purity compound in high yield, with reduced production cost/time as compared to a conventional method. | 2011-03-24 |
20110071303 | METHODS OF PREPARING IMIDAZOLE-BASED COMPOUNDS - Methods of preparing imidazole-based compounds are disclosed. Particular compounds are of formula I: | 2011-03-24 |
20110071304 | AROMATIC AMIDE DERIVATIVE - A compound represented by the following general formula (I) (R | 2011-03-24 |
20110071305 | PRODUCTION OF 5-MEMBERED AND 6-MEMBERED CYCLIC ESTERS OF POLYOLS - Described herein are improved methods for the preparation of 5- and 6-membered cyclic mono and diesters of sugar alcohols and anhydrosugar alcohols by reaction with an organic acid RCOOH over a solid acidic substrate. The process is adaptable to a continuous process for simultaneously making and separating the cyclic esters from the sugar alcohols and anhydrosugar alcohols under mild conditions using the solid acid substrate as both the catalyst and a chromatographic bed for separation. The reactions are performed at mild temperatures of 700 C to 1000 C and the formation of the cyclic esters is nearly quantitative. Also described is a method for making 5- and 6-membered cyclic mono and diesters of sugar alcohols and anhydrosugar alcohols using microwave irradiation in the presence of the organic acid. | 2011-03-24 |
20110071306 | BIOMASS REFINING BY SELECTIVE CHEMICAL REACTIONS - A method is disclosed for the acid hydrolysis of carbohydrates in or from biomass, using a solvent system including an aqueous ether, where the ether form a majority of the system, which affords high yields to the platform chemicals such as 2-furfural and 5-hydroxymethylfurfural (5-HMF). The later can also undergo a domino reaction to chemicals including levulinic acid, particularly with oxygenated anions and greater water content. A total dissolution and reaction of biomass occurs under a range of relatively mild conditions (combined Severity range ˜2.2-2.6). Lignin and lignin derived products can be easily separated by precipitation. | 2011-03-24 |
20110071307 | PROCESS FOR PRODUCING EPOXY (METHA)ACRYLATE - An object of the present invention is to provide a process for producing an epoxy (meth)acrylate safely with good productivity, and the invention provides a process for continuously producing an epoxy (meth)acrylate, containing causing a mixed liquid of a compound (A) having a carboxyl group and a (meth)acryloyl group and a compound (B) having an epoxy group to pass continuously and densely through a tubular microchannel formed in a heat-conducting reaction device, and reacting the carboxyl group of the compound (A) with the epoxy group of the compound (B), in which the tubular microchannel in the reaction device has a space size making a fluid cross-sectional area, through which the mixed liquid passes densely, of from 0.1 to 4.0 mm | 2011-03-24 |
20110071308 | PROCESS FOR PREPARING CRYSTALS BASED ON A FATTY ACID ESTER - The present invention relates to an improved process for preparing a fluid concentrated ingredient based on crystals based on a fatty acid ester, and also to the use of this fluid concentrated ingredient. | 2011-03-24 |
20110071309 | Methods and Systems for Utilization of HCI - Systems and methods are disclosed for generating a proton removing agent and an acidic solution in a low voltage electrochemical system and utilizing the proton removing agent to sequester carbon dioxide from a waste gas in a carbon dioxide sequestration system and utilizing the acidic solution to catalyze at least one step of a chemical syntheses in combination with a plant based material. | 2011-03-24 |
20110071310 | DIAMINO ACID DERIVATIVE STARTING MATERIAL, MANUFACTURING METHOD THEREOF, AND DIAMINO ACID DERIVATIVE MANUFACTURING METHOD - Provided is an efficient technology for synthesizing diamino acids (diamino acid derivatives). Disclosed is a manufacturing method for diamino acid derivatives wherein the fluorenyl groups of the diamino acid derivative starting materials represented by General Formula [II] or [IV] are removed. | 2011-03-24 |
20110071311 | PRODUCTION OF ETHYLENICALLY UNSATURATED ACIDS OR ESTERS THEREOF - A production process for the manufacture of ethylenically unsaturated acids or esters thereof is described. The process includes the steps of reaction of an alkanoic acid, or ester of an alkanoic acid, of the formula R | 2011-03-24 |
20110071312 | INTEGRATED PROCESS FOR THE PRODUCTION OF VINYL ACETATE FROM ACETIC ACID VIA ETHYLENE - This invention provides an integrated two stage economical process for the production of vinyl acetate monomer (VAM) from acetic acid in the vapor phase. First, acetic acid is selectively hydrogenated over a hydrogenating catalyst composition to form ethylene either in a single reactor zone or in a dual rector zone wherein the intermediate hydrogenated products are either dehydrated and/or cracked to form ethylene. In a subsequent second stage so formed ethylene is reacted with molecular oxygen and acetic acid over a suitable catalyst to form VAM. In an embodiment of this invention reaction of acetic acid and hydrogen over a hydrogenation catalyst and subsequent reaction over a dehydration catalyst selectively produces ethylene, which is further mixed with acetic acid and molecular oxygen and reacted over a supported palladium/gold/potassium catalyst. | 2011-03-24 |
20110071313 | PROCESS FOR PRODUCING AROMATIC CARBOXYLIC ACID - A process for allowing an oxidation reaction efficiently to produce an object aromatic carboxylic acid with an efficient productivity by improving a catalyst activity even in the presence of a relatively small amount of a catalyst is provided. | 2011-03-24 |
20110071314 | PROCESS FOR PRODUCING AROMATIC POLYCARBOXYLIC ACID - A process for producing an aromatic polycarboxylic acid in which all alkyl groups are converted into carboxyl groups in a high yield by decreasing a residual amount of an intermediate product is provided. The process comprises oxygen-oxidizing an aromatic compound having a plurality of alkyl groups (e.g., durene) in the presence of a catalyst containing a cyclic imino unit having an N—OR group (wherein R represents a hydrogen atom or a protecting group for a hydroxyl group) and a transition metal co-catalyst (e.g., a cobalt compound, a manganese compound, and a zirconium compound) under heating in a lower-temperature zone and a higher-temperature zone to produce an aromatic polycarboxylic acid in which a plurality of alkyl groups are oxidized into carboxyl groups. In an initial stage of the reaction, the reaction may be conducted in a first lower-temperature zone (a reaction temperature of 60 to 120° C. and a second lower-temperature zone (an intermediate temperature zone) (a reaction temperature of 100 to 140° C.); and then, in a latter stage of the reaction, the reaction may be conducted in a higher-temperature zone (a reaction temperature of 110 to 150° C.). | 2011-03-24 |
20110071315 | PROCESSES FOR THE PREPARATION OF AMIDES - The invention relates to a process for the preparation of intermediates useful in the preparation of fungicidally active phenylpropargylether derivatives. The process involves coupling of carboxylic acid with an amine in (a) the absence of a catalyst; (b) the presence of a boronic acid catalyst. | 2011-03-24 |
20110071316 | Unsymmetrical Ligand Sources, Reduced Symmetry Metal-Containing Compounds, and Systems and Methods Including Same - The present invention provides metal-containing compounds that include at least one β-diketiminate ligand, and methods of making and using the same. In some embodiments, the metal-containing compounds are homoleptic complexes that include unsymmetrical β-diketiminate ligands. In other embodiments, the metal-containing compounds are heteroleptic complexes including at least one β-diketiminate ligand. The compounds can be used to deposit metal-containing layers using vapor deposition methods. Vapor deposition systems including the compounds are also provided. Sources for β-diketiminate ligands are also provided. | 2011-03-24 |
20110071317 | HALOGENATED DIARYLAMINE COMPOUND AND SYNTHESIS METHOD THEREOF - An object is to provide a new halogenated diarylamine compound serving as a source material for synthesis of a variety of diarylamine compounds and triarylamine compounds and a synthesis method of the new halogenated diarylamine compound. A halogenated diarylamine compound represented by the following general formula (G1) and a synthesis method thereof are provided. Note that a variety of diarylamine compounds and triarylamine compounds can be synthesized using the halogenated diarylamine compound represented by the following general formula (G1). | 2011-03-24 |
20110071318 | METHOD AND APPARATUS FOR PRODUCING MONO-LOWER-ALKYL MONOALKANOLAMINE - A reaction column ( | 2011-03-24 |
20110071319 | METHOD FOR PREPARING HALOGENATED ORGANOPHOSPHINES - The present application relates to a process for preparing a halogenated organophosphine, comprising reacting a primary or secondary organophosphine with a halogenating agent selected from (A) a compound of formula (I): (HaI) | 2011-03-24 |
20110071320 | Allylic Oxidation Method for the Preparation of Fragrances Using Metal-Organic Compounds and Gold Catalysts - The present invention refers to a method for allylic catalytic oxidation to obtain α,β-unsaturated ketones and alcohols from bicyclic compounds reacted with oxygen and catalysts comprising metal-organic compounds and gold nanoparticles. The present invention also relates to a method for the preparation of fragrances using the above methods or products of the above method. | 2011-03-24 |
20110071321 | METHOD FOR SEPERATING 1-BUTENE FROM C4-CONTAINING HYDROCARBON STREAMS BY HYDROFORMYLATION - The invention relates to a method for separating 1-butene from C | 2011-03-24 |
20110071322 | METHOD FOR THE SYNTHESIS OF DIALKOXY ALKANES BY MEANS OF THE SELECTIVE OXIDATION OF ALCOHOLS - The invention relates to a method for the synthesis of dialkoxyalkanes by means of the partial selective oxidation of a light alcohol. According to said method, the light alcohol is oxidised in the presence of molecular oxygen or a gas containing molecular oxygen, and a solid oxidation catalyst based on at least one metal in a reactive medium comprising a gaseous phase containing an acid compound according to the Pearson classification, having a pKa of less than 6.3 in solution in water. The reaction is carried out in a vapour or in a liquid phase. | 2011-03-24 |
20110071323 | Method For Producing 1,2-Propanediol By Hydrogenolysis Of Glycerin - The invention relates to a method for producing 1,2-propanediol, in that a liquid phase comprising at least 95 wt.-% glycerin is reacted with hydrogen in the presence of a copper-containing, powdered catalyst in a continuously operated stirred reactor at a pressure of 50 to 90 bar, wherein the stationary yield of the reaction is at least 60%. | 2011-03-24 |
20110071324 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions - The invention relates to a method for the liquid-liquid extraction of alcohols from aqueous solutions using at least one ionic liquid containing a tetra-cyanoborate anion as solvent. | 2011-03-24 |
20110071325 | PRODUCTION PROCESS AND PURIFICATION PROCESS FOR 1,2,3,4-TETRACHLOROHEXAFLUOROBUTANE - It is an object of the present invention to provide a process for producing 1,2,3,4-tetrachlorohexafluorobutane industrially inexpensively and efficiently by utilizing expensive fluorine gas efficiently and to provide a process which is capable of stably producing 1,2,3,4-tetrachlorohexafluorobutane and in which, by carrying out fluorination reaction at a low temperature, side reactions such as formation of a low-boiling substance due to cleavage of C—C bonds and formation of an excess fluoride are difficult to occur. The process for producing 1,2,3,4-tetrachlorohexafluorobutane of the present invention is characterized in that it includes feeding fluorine gas to 1,2,3,4-tetrachlorobutane using plural reactors in the presence of a solvent and in the absence of a catalyst to allow the 1,2,3,4-tetrachlorobutane and the fluorine gas to react with each other, wherein a part or all of unreacted fluorine gas discharged from one reactor is introduced into a reactor different from said one reactor. | 2011-03-24 |
20110071326 | PROCESS FOR CONVERTING GASEOUS ALKANES TO LIQUID HYDROCARBONS - Embodiments disclose a process for converting gaseous alkanes to higher molecular weight hydrocarbons, olefins or mixtures thereofs wherein a gaseous feed containing alkanes may be reacted with a dry bromine vapor to form alkyl bromides and hydrobromic acid vapor. The mixture of alkyl bromides and hydrobromic acid then may be reacted over a synthetic crystalline alumino-silicate catalyst, such as a ZSM-5 or an X or Y type zeolite, at a temperature of from about 250° C. to about 500° C. so as to form hydrobromic acid vapor and higher molecular weight hydrocarbons, olefins or mixtures thereof. Various methods are disclosed to remove the hydrobromic acid vapor from the higher molecular weight hydrocarbons, olefins or mixtures thereof and to generate bromine from the hydrobromic acid for use in the process. | 2011-03-24 |
20110071327 | PROCESS FOR CO-PRODUCING JET FUEL AND LPG FROM RENEWABLE SOURCES - The present invention generally relates to a method for producing an isoparaffinic product useful as jet fuel from a renewable feedstock. The method may also include co-producing a jet fuel and a liquefied petroleum gas (LPG) fraction from a renewable feedstock. The method includes hydrotreating the renewable feedstock to produce a hydrotreating unit heavy fraction that includes n-paraffins and hydroisomerizing the hydrotreating unit heavy fraction to produce a hydroizomerizing unit heavy fraction that includes isoparaffins. The method also includes recycling the hydroisomerizing unit heavy fraction through the hydroisomerization unit to produce an isoparaffinic product that may be fractionated into a jet fuel and an LPG fraction. The present invention also relates to a jet fuel produced from a renewable feedstock having improved cold flow properties. | 2011-03-24 |
20110071328 | Selective Hydrogenation of Dienes in the Manufacture of MLAB - A process and catalyst are presented for the selective hydrogenation of branched diolefins and acetylenes to olefins. The process uses a catalyst having large pores, and a minimal amount of micropores. The catalyst is designed to have minimal diffusional resistance through the large pores, and to minimize the hydrogenation of olefins to paraffins. | 2011-03-24 |
20110071329 | Hydroalkylation of Aromatic Compounds Using EMM-12 - This disclosure relates to a process for manufacturing a mono-cycloalkyl-substituted aromatic compound, said process comprising contacting a feedstock comprising an aromatic compound and hydrogen under hydroalkylation reaction conditions with a catalyst system comprising a molecular sieve and at least one metal with hydrogenation activity, wherein said molecular sieve has, in its as-synthesized form and in calcined form, an X-ray diffraction pattern including peaks having a d-spacing maximum in the range of 14.17 to 12.57 Angstroms, a d-spacing maximum in the range of 12.1 to 12.56 Angstroms. | 2011-03-24 |
20110071330 | Offgas Stream Direct Contact Condenser - Methods and systems for the dehydrogenation of hydrocarbons include a direct contact condenser to remove compounds from an offgas process stream. The reduction of compounds can decrease duty on the offgas compressor by removing steam and aromatics from the offgas. The dehydrogenation reaction system can be applicable for reactions such as the dehydrogenation of ethylbenzene to produce styrene, the dehydrogenation of isoamiline to produce isoprene, or the dehydrogenation of n-pentene to produce piperylene. | 2011-03-24 |
20110071331 | PROCESS FOR CONVERTING ETHANE INTO LIQUID ALKANE MIXTURES - The invention relates to a process for converting ethane into liquid mixture of (C | 2011-03-24 |
20110071332 | ABSORBER DEMETHANIZER FOR FCC PROCESS - A process for recovering ethylene is disclosed, the process including: recovering a ethylene-containing stream comprising methane, ethylene, and nitrogen oxides from at least one of an ethylene production process and an ethylene recovery process; separating the ethylene-containing stream via extractive distillation using at least one C | 2011-03-24 |
20110071333 | PROCESS FOR NEUTRALIZATION OF A CATIONIC ZEOLITE - The invention relates to a process for neutralization of a cationic zeolite that is at least partially exchanged with one or more monovalent and/or multivalent cations. The neutralization process comprises at least the stages for dissolution of a basic salt in an anhydrous organic solvent, degassing this solution by bubbling a dry inert gas, suspending the zeolite in this solution under dry inert gas, filtering and washing the solid by an anhydrous organic solvent, and calcination in the presence of oxygen and under a dry gaseous stream. The invention also relates to the use of neutralized zeolites for the separation or the purification of hydrocarbon feedstocks. | 2011-03-24 |
20110071334 | FOAMING DECONTAMINATING AQUEOUS SOLUTION - The invention relates to a foaming decontaminating aqueous solution, characterized in that it comprises, by weight relative to the total weight of the composition:
| 2011-03-24 |
20110071335 | APPLICATIONS OF ALTERNATING MAGNETIC FIELDS ON MAGNETIC NANOPARTICLES - Embodiments include applying or generating an alternating magnetic field near an affected area of a subject to be treated. When magnetic nanoparticles are located in the affected area, the magnetic nanoparticles are oscillated by the alternating magnetic field, which causes the magnetic nanoparticles to be dispersed within the affected area, break up the affected area, and/or heat the affected area. | 2011-03-24 |
20110071336 | HARD-WIRED IMPLANTED CONTROLLER SYSTEM - A circulatory assist system is disclosed, the system including an implantable electrical device having an electric motor, an implantable controller connected to the implantable electrical device, and an implantable power source connected to the controller for supplying power to the controller. The controller is attachable to a first side of a percutaneous connector. A second side of the percutaneous connector, opposite to the first side, allows external connectivity to said controller. | 2011-03-24 |
20110071337 | HEART ASSIST DEVICE - A ventricular assist device comprising a housing defining an interior space, at least two ports opening into said interior space, and at least one pump for pumping blood between the ports through said interior space, the ports and interior space providing a continuous blood flow path that is not interrupted by valves. | 2011-03-24 |
20110071338 | HEART ASSIST DEVICE WITH EXPANDABLE IMPELLER PUMP - An impeller includes a hub and at least one blade supported by the hub. The impeller has a stored configuration in which the blade is compressed so that its distal end moves towards the hub, and a deployed configuration in which the blade extends away from the hub. The impeller may be part of a pump for pumping fluids, such as pumping blood within a patient. A blood pump may include a cannula having a proximal portion with a fixed diameter, and a distal portion with an expandable diameter. The impeller may reside in the expandable portion of the cannula. The cannula may have a compressed diameter which allows it to be inserted percutaneously into a patient. Once at a desired location, the expandable portion of the cannula may be expanded and the impeller expanded to the deployed configuration. A flexible drive shaft may extend through the cannula for rotationally driving the impeller within the patient's body. | 2011-03-24 |
20110071339 | METHOD OF DETERMINING A GAIN SETTING OF A BONE-ANCHORED HEARING AID - The invention regards a method for determining a gain setting of a bone-anchored hearing aid comprising a bone anchor, the proximal and the distal ears having respective first and second monaural bone-conduction hearing thresholds, the first monaural bone-conduction hearing threshold being higher than the second monaural bone-conduction hearing threshold. The method comprises: obtaining respective first and second measured monaural bone-conduction hearing thresholds for the proximal and the distal ear; and determining the gain setting in dependence on the first and the second measured monaural bone-conduction hearing thresholds. | 2011-03-24 |
20110071340 | METHODS AND SYSTEMS FOR TREATING TINNITUS - Methods and systems for treating tinnitus are provided. Some embodiments include a method of providing a primary audio signal having a primary peak portion substantially centered at about a tinnitus frequency of a patient. The method may also include combining the primary audio signal with a general audio signal to generate a combined sound. The method may also include exposing the patient to the combined sound so that the patient hears the combined sound, to diminish a perception by the patient of tinnitus. | 2011-03-24 |
20110071341 | IMPLANTABLE RESTRICTION SYSTEM WITH RELEASE MECHANISM - An apparatus for regulating the functioning of a patient's organ or duct includes an elongated member having a first end and a second end. A fastener is disposed on the first end of the elongated member. The fastener is configured to engage the second end of the elongated member so that the elongated member forms a loop around the organ or duct. A tension element is disposed for movement within the elongated member. A drive element is associated with and engaging the tension element for causing the tension element to control the tension applied by the elongated member against a patient's body organ or duct. A release mechanism is provided for the tension element. | 2011-03-24 |
20110071342 | SPACE ENSURING DEVICE - In a pericardioscopic procedure, without providing an endoscope or surgical instrument with special space ensuring means and without unnecessarily dilating the pericardial space, a space necessary for operation of the endoscope or surgical instrument is ensured, so that maneuverability is improved while suppressing complications. Provided is a space ensuring device comprising: a pericardium pressing part for pressing a pericardium from the pericardial space side; a heart pressing part for pressing the surface of a heart from the pericardial space side; and an interconnecting part interconnecting the pericardium pressing part and the heart pressing part, wherein the interconnecting part generates the resilient force enabling expansion against a pressure applied by a pericardium and a heart so as to ensure a space between the pericardium pressing part and the heart pressing part. | 2011-03-24 |
20110071347 | CANNULA MOUNTING FIXTURE - A robotic surgical system is configured with rigid, curved cannulas that extend through the same opening into a patient's body. Surgical instruments with passively flexible shafts extend through the curved cannulas. The cannulas are oriented to direct the instruments towards a surgical site. Various port features that support the curved cannulas within the single opening are disclosed. Cannula support fixtures that support the cannulas during insertion into the single opening and mounting to robotic manipulators are disclosed. The support fixtures include arms that swing in an arc to insert a curved cannula, repositionable arms coupled to a stable cannula base, and an insertion cap that holds a cannula. A teleoperation control system that moves the curved cannulas and their associated instruments in a manner that allows a surgeon to experience intuitive control is disclosed. | 2011-03-24 |
20110071348 | TROCART - The invention relates to a trocar including a main tube ( | 2011-03-24 |
20110071349 | ENDOSCOPE SYSTEM FOR TREATMENT OF SINUSITIS - An endoscope includes a substantially rigid shaft having a distal end and a proximal portion, the shaft having a first lumen and a second lumen separate from the first lumen, the second lumen containing one or more objective lenses disposed at the distal end thereof. A housing is mounted on the proximal portion of the shaft, the housing including an eyepiece mount and a light input port. An image fiber bundle is disposed in the second lumen, the image fiber bundle extending proximally from adjacent the one or more objective lenses to the eyepiece mount. An illumination fiber bundle is disposed in the second lumen, the illumination fiber bundle extending proximally from the distal end of the shaft to the light input port. | 2011-03-24 |
20110071350 | APPLICATOR FOR ENDOSCOPIC TREATMENT OF BILIARY DISEASE - The application discloses devices, systems, kits and methods for treating biliary disease. Device comprise, for example, a component configured for deployment to a lumen of a gallbladder or gallbladder duct which has a proximal end and a distal end with a lumen extending therethrough and a fluid or gas delivery apparatus at its distal end. | 2011-03-24 |
20110071351 | APPARATUS AND METHOD FOR SIMULATION OF DIASTOLE AND VISUALIZING THE DIASTOLIC STATE OF AN AORTIC VALVE AND ROOT DURING CARDIAC SURGERY - A device for evaluating an aortic valve after opening an aorta distal to the aortic valve includes a body defining a chamber. The body has a generally circular proximal open end and a distal end, the proximal open end being configured to be reversibly attachable to one of the aorta and a short open tube distal to the aortic valve in a generally water-tight fashion. At least a portion of the body is transparent to view the aortic valve. Other embodiments of the device and related methods are further disclosed. | 2011-03-24 |
20110071352 | METHOD OF CONTROLLING ENDOSCOPE AND ENDOSCOPE - An endoscope | 2011-03-24 |
20110071353 | METHOD OF CONTROLLING ENDOSCOPE AND ENDOSCOPE - An endoscope | 2011-03-24 |
20110071354 | OVERTUBE AND MEDICAL PROCEDURE VIA NATURAL ORIFICE USING THE SAME - An overtube according to this invention includes: an insertion part, that is inserted into a subject and has a lumen, through which a device insertion part of a device for performing a medical procedure inside a body of the subject is removably inserted, the insertion part being inserted into the subject; and a tissue incising part that is disposed at a distal end side of the insertion part so as to cross the lumen and incises a tissue of the subject. | 2011-03-24 |
20110071355 | ENDOSCOPE APPARATUS - An endoscope apparatus comprises an insertion portion having an observation optical system attached onto the distal end portion thereof and having flexibility, a thrust generating portion for generating a thrust by rotation, formed beyond a predetermined length on an outer-peripheral surface of the insertion portion in a longitudinal-axis direction, a rotation device for rotating the thrust generating portion around the longitudinal axis, and a control portion for controlling a rotational speed of the thrust generating portion according to an insertion length of the thrust generating portion inserted in a subject. | 2011-03-24 |
20110071356 | Repeatably flexible surgical instrument - A flexible-shaft surgical instrument is provided that can be repeatably bent to one or more desired angles on demand by a user without the use of a special bending tool. The flexible-shaft surgical instrument can be repeatably bent and re-bent into multiple positions without plastic deformation of the flexible-shaft surgical instrument occurring in any of one or more bend portions. | 2011-03-24 |
20110071357 | ENDOSCOPIC FLUID CONTROL APPARATUS - An endoscopic fluid control apparatus is provided in an endoscope including a channel for performing suction and air-feed, and controls the suction and air-feed for the channel. The endoscopic fluid control apparatus includes air-feed channels which communicate with the one channel, a suction channel which communicates with the one channel, a first valve which is provided on the air-feed channels and opens only during the air-feed, and a second valve which is provided on an operation button to be operated for suction operation, and shuts off communication between one of the air-feed channels and another of the air-feed channels among the air-feed channels into which the operation button is inserted, when the operation button is operated to carry out the suction operation. | 2011-03-24 |
20110071358 | Fiber Optic Assisted Medical Lead - A medical device for placing a medical lead in the human body using minimally invasive techniques is described. One lead includes a lead body connected to a lead head having an aperture for providing fiber optic access to the interior of a helical electrode. The fiber optic shaft may be disposed within or along-side a drive shaft releasably coupled to the head to rotate the head. The drive shaft and lead body may be delivered using a delivery catheter. The delivery catheter can be advanced though a small incision to the target tissue site, and the site remotely visualized through the fiber optic scope extending through the lead head aperture. Some catheters include a distal mapping electrode readable from the catheter proximal portion or handle. The lead head can be rotated, rotating the helical electrode into the tissue, and the catheter, drive shaft, and fiber optic probe removed. In one use, epicardial pacing leads are placed on the posterior surface of the heart, aided by visualization and mapping to obtain optimal electrode placement and patient outcome. | 2011-03-24 |
20110071359 | Instrument Access Device - An instrument access device | 2011-03-24 |
20110071360 | Tissue Retractor and Method for Using the Retractor - A retractor for manipulating an object includes a body having proximal and distal ends and a retraction device with a head connected to the distal end of the body, a connector movably disposed in the body, and flexible needles of a shape memory material having a memory shape. The needles are connected to the connector and each have a distal tip. The memory shape of the needles include a portion with an arcuate shape biasing the needles in a memory direction out and away from the head and toward the body to position the distal tip of each of the needles closer to the body when the needles are fully extended out of the head than when the needles are only partially extended out of the head. An actuation device is connected to the proximal end of the body and operatively connected to the connector through the body, the actuation device, upon actuation thereof, moves the connector to selectively extend the needles out of the head in different directions and withdraw the needles into the head. | 2011-03-24 |
20110071361 | METHOD AND APPARATUS FOR COMBINED DISSECTION AND RETRACTION - A method and apparatus for dissecting a first layer of tissue from a second layer of tissue and thereafter holding open an anatomic space for the performance of a surgical procedure. The method includes steps of making an incision in a body, introducing a deflated balloon dissector into the incision, inflating the balloon dissector to effect dissection of the first layer of tissue from the second layer of tissue, deploying a retractor within the anatomic space in order to hold open the anatomic space, and optionally deflating or evacuating the balloon dissector to open a cavity for surgical manipulations. The apparatus includes a combined dissector-retractor having a balloon retractor disposed upon the surface of the balloon dissector and integrated therewith. | 2011-03-24 |
20110071362 | RETRACTOR TOOL - A retractor tool for retracting target tissue is provided for use with a medical probe. The retractor tool includes a guide piece that defines a probe channel and at least one retractor arm channel. Further, the retractor tool at least one retractor arm, each retractor arm passing through a corresponding retractor arm channel. | 2011-03-24 |
20110071363 | SYSTEM AND METHOD FOR USING PREDICTIVE MODELS TO DETERMINE LEVELS OF HEALTHCARE INTERVENTIONS - A computer implemented method may be used for targeting patients within a population for increased medical interventions. In one embodiment, predictive models are used to determine whether a patient is likely to be near the end of life, whether the patient's healthcare costs are stabilizing, whether the patient is likely to have high future healthcare costs, and whether the patient is likely to have high future clinical risk. In one embodiment, scores from these predictive models are used to determine the level of medical intervention for a particular patient. | 2011-03-24 |
20110071364 | Remote Patient Monitoring System and Method Thereof - This invention relates to a remote patient monitoring system and method thereof. The remote patient monitoring system comprises a portable electronic device, a remote monitor and a bio-signal detecting device which further comprises a plurality of bio-signal sensing modules, a wireless transmitting module and a control unit. The bio-signal detecting device is used for wearing on the body of user so that the bio-signal sensing modules can obtain a plurality of bio-signals form the user. The control unit is coupled to the bio-signal sensing modules and the wireless transmitting module. The control unit controls the wireless transmitting module to transmit the bio-signals to the portable electronic device. The portable electronic device transmits the bio-signals to the remote monitor. | 2011-03-24 |
20110071365 | METHOD AND APPARATUS FOR PROVIDING BLOOD GLUCOSE MANAGEMENT INFORMATION - An apparatus and method of providing blood glucose management information includes a determination unit that determines a similarity of a blood glucose change pattern of a user by comparing blood glucose information obtained from the user and stored blood glucose information, an extraction unit that extracts at least one piece of blood glucose information from the stored blood glucose information according to the similarity and generates extracted blood glucose information, and an interface unit which provides the blood glucose management information, which corresponds to the extracted blood glucose information, to the user. | 2011-03-24 |
20110071366 | Determination Of A Physiological Parameter - Methods and systems are provided for transmitting and receiving photon density waves to and from tissue, and processing the received waves using wavelet transforms to identify non-physiological signal components and/or identify physiological conditions. A pulse oximeter may receive the photon density waves from the tissue to generate a signal having phase and amplitude information. A phase signal may be proportional to a scattering by total particles in the tissue, and an amplitude signal may correlate to an absorption by certain particles, providing information on a ratio of different particles in the tissue. Processing the phase and amplitude signals with wavelet transforms may enable an analysis of signals with respect to time, frequency, and magnitude, and may produce various physiological data. For example, non-physiological noise components may be identified, and certain physiological conditions may be identified by processing scalograms of the original signals with patterns corresponding to certain physiological conditions. | 2011-03-24 |
20110071367 | PROBE FOR FLUID LEAK DETECTION WITH SPECIFIC DISTAL PART - A disposable medical probe for detecting a leak of physiological fluid comprising a support layer, a conductive layer on top of the support layer, the conductive layer comprising two conducting electrodes both placed exclusively on each side of a longitudinal axis, the conductive layer defining two zones: a proximal zone with two proximal electrode parts being placed parallel to each other and being spaced apart by a constant distance d, and a distal zone with two distal electrode parts being spaced apart from each other by a gap e greater than said distance d, where the distal zone of the electrodes defines an increase in the gap between the distal parts of the electrodes, followed by a decrease in the gap between the distal parts of the electrodes. | 2011-03-24 |
20110071368 | Medical Device Interface Customization Systems And Methods - Embodiments of the present disclosure relate to customization of user interfaces for medical devices. According to certain embodiments, patient monitors may include a device body designed to interface with interchangeable and removable faceplates. The faceplates may include input devices for controlling the patient monitor. Further, the properties of the input devices, such as the size, shape, labels, type, and location, may vary between faceplates. Further, in certain embodiments, the faceplates may include a memory for storing preferences associated with the user interface. | 2011-03-24 |
20110071369 | SPOT OR RASH TESTER - A spot or rash tester for meningitis ( | 2011-03-24 |
20110071370 | PHYSIOLOGICAL MEASUREMENT COMMUNICATIONS ADAPTER - A sensor interface is configured to receive a sensor signal. A transmitter generates a transmit signal. A receiver receives the signal corresponding to the transmit signal. Further, a monitor interface is configured to communicate a waveform to the monitor so that measurements derived by the monitor from the waveform are generally equivalent to measurements derivable from the sensor signal. | 2011-03-24 |
20110071371 | Wavelength-Division Multiplexing In A Multi-Wavelength Photon Density Wave System - Multi-wavelength photon density wave medical systems, methods, and devices are provided. In one embodiment, a multi-wavelength photon density wave patient monitor includes multiple light sources, a driving circuit, a fiber coupler, a sensor cable connector, a wavelength demultiplexer, detectors, and data processing circuitry. The driving circuit may modulate the light sources to produce several single-wavelength input photon density wave signals, which the fiber coupler may join into a multi-wavelength input signal. The sensor cable connector may provide this multi-wavelength input signal to a sensor attached to the patient and receive a multi-wavelength output signal. The wavelength demultiplexer may separate the multi-wavelength output signal into single-wavelength output signals for detection by the detectors. Based on a comparison of one of the single-wavelength output signals to a corresponding one of the single-wavelength input signals, the data processing circuitry may determine a physiological parameter of the patient. | 2011-03-24 |